Phreesia (NYSE:PHR) SVP Sells $11,253.06 in Stock

Phreesia, Inc. (NYSE:PHR) SVP Amy Beth Vanduyn sold 687 shares of the firm’s stock in a transaction dated Thursday, January 15th. The stock was sold at an average price of $16.38, for a total value of $11,253.06. Following the transaction, the senior vice president owned 159,551 shares of the company’s stock, valued at $2,613,445.38. This trade represents a 0.43% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Amy Beth Vanduyn also recently made the following trade(s):

• On Friday, January 16th, Amy Beth Vanduyn sold 2,202 shares of Phreesia stock. The shares were sold at an average price of $16.36, for a total transaction of $36,024.72.
• On Thursday, January 8th, Amy Beth Vanduyn sold 2,602 shares of Phreesia stock. The stock was sold at an average price of $17.01, for a total transaction of $44,260.02.

Phreesia Stock Up 1.2%

Shares of NYSE PHR opened at $15.80 on Friday. The company’s 50 day moving average price is $17.81 and its 200-day moving average price is $22.98. The company has a debt-to-equity ratio of 0.01, a quick ratio of 2.44 and a current ratio of 2.44. Phreesia, Inc. has a 52-week low of $15.40 and a 52-week high of $32.76. The company has a market capitalization of $952.58 million, a P/E ratio of -157.98 and a beta of 0.61.

Phreesia (NYSE:PHR) last announced its earnings results on Monday, December 8th. The company reported $0.10 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.01) by $0.11. The business had revenue of $120.33 million during the quarter, compared to the consensus estimate of $119.98 million. Phreesia had a negative net margin of 1.16% and a negative return on equity of 1.31%. Phreesia’s quarterly revenue was up 12.7% on a year-over-year basis. During the same quarter last year, the firm earned ($0.25) earnings per share. Equities analysts forecast that Phreesia, Inc. will post -1.1 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on PHR shares. Barclays decreased their target price on Phreesia from $26.00 to $24.00 and set an “overweight” rating for the company in a research note on Tuesday, December 16th. Mizuho reduced their price objective on shares of Phreesia from $36.00 to $28.00 and set an “outperform” rating for the company in a research report on Wednesday, December 10th. Needham & Company LLC reiterated a “buy” rating and set a $35.00 target price on shares of Phreesia in a research report on Monday, December 8th. Wells Fargo & Company initiated coverage on shares of Phreesia in a research note on Thursday, January 8th. They set an “overweight” rating and a $30.00 target price on the stock. Finally, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Phreesia in a research note on Friday, October 31st. Seventeen equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, Phreesia has an average rating of “Moderate Buy” and an average target price of $30.06.

Institutional Trading of Phreesia

Hedge funds have recently bought and sold shares of the business. Massachusetts Financial Services Co. MA acquired a new position in Phreesia during the fourth quarter worth $231,000. Moody National Bank Trust Division increased its position in shares of Phreesia by 63.8% during the fourth quarter. Moody National Bank Trust Division now owns 195,944 shares of the company’s stock worth $3,315,000 after acquiring an additional 76,345 shares in the last quarter. SG Americas Securities LLC acquired a new stake in shares of Phreesia in the 4th quarter worth about $1,203,000. Diversified Trust Co. lifted its position in Phreesia by 12.2% in the 4th quarter. Diversified Trust Co. now owns 51,422 shares of the company’s stock valued at $870,000 after acquiring an additional 5,600 shares in the last quarter. Finally, Tudor Investment Corp ET AL acquired a new position in Phreesia during the 3rd quarter valued at about $4,173,000. Institutional investors and hedge funds own 92.10% of the company’s stock.

About Phreesia

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.